• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Post-mastectomy breast reconstruction may improve survival outcomes

byChaz Carrier
March 7, 2015
in Obstetrics, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Breast reconstruction patients had an observed survival advantage over controls after adjusting for age, tumor size, lymph node status and size of hospital.

2. There was no significant difference in risk of death from breast cancer between breast reconstruction patients and controls in the early and late stages of follow-up.

Evidence Rating Level: 2 (Good)    

Study Rundown: Breast cancer is one of the most frequently diagnosed cancers today. Mastectomy is often the treatment of choice, however this procedure leaves a long-term deformity resulting in a potentially reduced patient quality of life. Breast reconstruction is a surgical option that can be used to restore cosmesis post-mastectomy, but it is significantly underused due to concerns that there may be impaired detection of locoregional recurrence. In this study, the authors therefore evaluated whether breast reconstruction following mastectomy had any effect on overall or breast cancer specific survival outcomes. No evidence of worse survival outcomes in the breast reconstruction group compared with the mastectomy alone group was appreciated. Breast reconstruction was associated with apparent survival advantage, namely at the intermediate stage of follow-up after adjustment of confounders. An important strength of this study was its large sample size with a follow-up period of over 20 years. However, its limitations included an observational study design and the potential for missed confounders to explain apparent survival advantage in the breast reconstruction group.

Click to read the study in Plastic and Reconstructive Surgery

Relevant Reading: Delayed breast reconstruction with implants after invasive breast cancer does not impair prognosis.

In-Depth [retrospective study]: A total of 758 matched pairs of women who underwent mastectomy alone and women who underwent additional post-mastectomy breast reconstruction were included for study.  Population-based data from the Ontario Cancer Registry (1980 to 1990) was used to identify patients and the median follow-up was 23.4 years (IQR 1.1 to 33.0 years). An extended Cox hazards model was then used to compare overall and breast cancer-specific survival between the mastectomy alone and breast reconstruction groups. Secondary analysis was done to examine whether there was any difference across early, intermediate and late stages of follow-up. Compared to the mastectomy alone group, the breast reconstruction group had similar survival outcomes during the first 10 years(breast cancer-specific survival HR 0.94, 95%CI 0.76-1.15, p = 0.54) and last 10 years (breast cancer-specific survival HR 0.59, 95%CI 0.31-1.10, p = 0.097) of follow-up. Between 10-20 years of follow-up, there was a significant survival advantage for the breast reconstruction group over the mastectomy alone group (breast cancer-specific survival HR 0.63, 95%CI 0.56-0.86, p = 0.0042).

RELATED REPORTS

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

Several factors influence health programs conducted in the African American Church

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerbreast reconstructionplastic surgery
Previous Post

ADHD associated with increased mortality rates

Next Post

Head cooling improves outcomes in neonatal encephalopathy [Classics Series]

RelatedReports

2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

June 16, 2022
#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
StudyGraphics

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

May 18, 2022
Wellness

Several factors influence health programs conducted in the African American Church

May 18, 2022
#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in  premenopausal women with ER+ breast cancer and ovarian suppression
StudyGraphics

#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in premenopausal women with ER+ breast cancer and ovarian suppression

May 3, 2022
Next Post
Classics Series, Landmark Trials in Medicine

Head cooling improves outcomes in neonatal encephalopathy [Classics Series]

Women electing abortion more likely to be victims of domestic violence

GnRH agonist for ovarian preservation in breast cancer (POEMS Study)

Improved air quality linked to better lung function in children

Improved air quality linked to better lung function in children

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans
  • Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality
  • Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.